医疗设备通讯H2-2023

Disclaimer This presentation is being furnished by Cascadia Capital, LLC (“Cascadia”) to the recipient and is intended as an outline of matters for informational and discussion purposes only. Theinformation contained in this presentation, including any market data and industry information, has been derived entirely from material supplied by public sources, which Cascadia believes tobe accurate; however, no independent verification of such material has been made and any estimates made by Cascadia based on material from such sources are by their nature inherentlyinexact. Accordingly, Cascadia does not make any representation or warranty, nor is any such representation or warranty implied, as to the accuracy or completeness of the informationcontained herein, and Cascadia is not responsible for any misstatements or omissions in this presentation. Cascadia has no obligation to update the information contained herein. This presentation may include certain statements, estimates and projections with respect to a company, or industry, including certain forward-looking statements. Any such statements,estimates and projections reflect various assumptions, which may or may not prove to be accurate or correct, concerning anticipated results and are subject to significant business, economicand competitive uncertainties and contingencies, all of which are beyond the control of Cascadia. Accordingly, there can be no assurance that such statements, estimates and projections willbe realized. Such statements, estimates and projections are likely to vary from actual results and those variations may be material. No such statements, estimates or projections constitute aguarantee, promise, forecast or prediction of the future and Cascadia does not represent or warrant that any estimates or projections will be achieved. Cascadia neither: (i) acceptsresponsibility for or makes representations as to the accuracy or completeness of any forward-looking statements, estimates or projections contained in this presentation, nor (ii) undertakesany obligation to update or revise any forward-looking statements, estimates or projections for any reason after the date of this presentation. All financial data in this presentation is providedfor informational and discussion purposes only. Past performance is not necessarily indicative, or a guarantee, of future results. There can be no assurance that any Cascadia project will achieve comparable results as those presentedherein. The information contained in this presentation is strictly confidential and may not be reproduced, distributed, disclosed or disseminated, in whole or in part, to any third party without the priorwritten consent of Cascadia. Cascadia Medical Equipment Newsletter: H2 2023 Cascadia Medical Equipment Team Cascadia Medical Equipment Tombstones Newsletter Overview Principal MarketCoverage SpecializedMarket Coverage Updates from Cascadia & the Medical Equipment Team The Medical Equipment team is thrilled to welcomeBen Frekingto the practice, whojoins us from Lazard with a wealth of deep industry relationships and expertise MarketLandscape Cascadia is also excited to announce the acquisition ofThreadstone Capital, a leadingadvisor to high-growth consumer, retail, and beauty brands. The integration of theThreadstone team, led by Managing DirectorWilliam Susman,will broaden Cascadia’sConsumer, Retail & E-Commerce practice and expand Cascadia’s geographic footprintwith an established presence in New York City Michael ButlerCEO & Chairman, Cascadia About Cascadia “I believe this is the first tangible step toward theopening of the financing and M&A markets. Thenext will be when there is a rate cut. Markets havebeen waiting for a signal that rate increases areover, and this is a very positive sign.” There has been a significant amount of capital sitting on the sidelines that has created apent-up demand for private M&A and capital financing, and the Fed's signal of peak ratescoming out of their December meeting could be the catalyst the market needs. A loweredcost of capital should stimulate the overall economy and increase M&A activity, which iswhy we believe2024 will see an onslaught of new deals in the early months Appendix Cascadia Market Insights: H2 2023 State of the Market Rise in Adoption of Refurbished Equipment Medical Equipment Parts, Systems, and Services:After an active M&A period from 2021 to 2022, medical equipment parts, Refurbished medical equipment is gaining popularityamong healthcare facilities due to thesubstantial costsaving opportunities, often up to50-80%(2)comparedto new equipment, creating significant cost alleviationwithout sacrificing patient outcomesA12.2% CAGRis expected for the refurbished medicalequipment market size as compared to a projected3.0%CAGRfor new medical equipment(1) systems, and services deal flow has slightly slowed in 2023 in the backdrop ofbroader M&A uncertainty. Despite the lighter deal volume over the past year